• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Market characteristics
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Application
o Market segments
o Comparison by Application
o Memory enhancement – Market size and forecast 2019-2024
o Mood and depression alleviation – Market size and forecast 2019-2024
o Attention and focus improvement – Market size and forecast 2019-2024
o Others – Market size and forecast 2019-2024
o Market opportunity by Application
• Customer Landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o APAC – Market size and forecast 2019-2024
o South America – Market size and forecast 2019-2024
o MEA – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Competitive scenario
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Amway Corp.
o Archer Daniels Midland Co.
o Arkopharma Laboratories
o BASF SE
o Bayer AG
o Glanbia Plc
o GNC Holdings Inc.
o Herbalife Nutrition Ltd.
o Lonza Group Ltd.
o NOW Health Group Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: Application – Market share 2019-2024 (%)
• 22: Comparison by Application
• 23: Memory enhancement – Market size and forecast 2019-2024 ($ million)
• 24: Memory enhancement – Year-over-year growth 2019-2024 (%)
• 25: Mood and depression alleviation – Market size and forecast 2019-2024 ($ million)
• 26: Mood and depression alleviation – Year-over-year growth 2019-2024 (%)
• 27: Attention and focus improvement – Market size and forecast 2019-2024 ($ million)
• 28: Attention and focus improvement – Year-over-year growth 2019-2024 (%)
• 29: Others – Market size and forecast 2019-2024 ($ million)
• 30: Others – Year-over-year growth 2019-2024 (%)
• 31: Market opportunity by Application
• 32: Customer landscape
• 33: Market share by geography 2019-2024 (%)
• 34: Geographic comparison
• 35: North America – Market size and forecast 2019-2024 ($ million)
• 36: North America – Year-over-year growth 2019-2024 (%)
• 37: Europe – Market size and forecast 2019-2024 ($ million)
• 38: Europe – Year-over-year growth 2019-2024 (%)
• 39: APAC – Market size and forecast 2019-2024 ($ million)
• 40: APAC – Year-over-year growth 2019-2024 (%)
• 41: South America – Market size and forecast 2019-2024 ($ million)
• 42: South America – Year-over-year growth 2019-2024 (%)
• 43: MEA – Market size and forecast 2019-2024 ($ million)
• 44: MEA – Year-over-year growth 2019-2024 (%)
• 45: Key leading countries
• 46: Market opportunity by geography ($ million)
• 47: Impact of drivers and challenges
• 48: Vendor landscape
• 49: Landscape disruption
• 50: Industry risks
• 51: Vendors covered
• 52: Market positioning of vendors
• 53: Amway Corp. – Overview
• 54: Amway Corp. – Product and service
• 55: Amway Corp. – Key offerings
• 56: Amway Corp. – Key customers
• 57: Amway Corp. – Segment focus
• 58: Archer Daniels Midland Co. – Overview
• 59: Archer Daniels Midland Co. – Business segments
• 60: Archer Daniels Midland Co. – Key offerings
• 61: Archer Daniels Midland Co. – Key customers
• 62: Archer Daniels Midland Co. – Segment focus
• 63: Arkopharma Laboratories – Overview
• 64: Arkopharma Laboratories – Product and service
• 65: Arkopharma Laboratories – Key offerings
• 66: Arkopharma Laboratories – Key customers
• 67: Arkopharma Laboratories – Segment focus
• 68: BASF SE – Overview
• 69: BASF SE – Business segments
• 70: BASF SE – Key offerings
• 71: BASF SE – Key customers
• 72: BASF SE – Segment focus
• 73: Bayer AG – Overview
• 74: Bayer AG – Business segments
• 75: Bayer AG – Key offerings
• 76: Bayer AG – Key customers
• 77: Bayer AG – Segment focus
• 78: Glanbia Plc – Overview
• 79: Glanbia Plc – Business segments
• 80: Glanbia Plc – Key offerings
• 81: Glanbia Plc – Key customers
• 82: Glanbia Plc – Segment focus
• 83: GNC Holdings Inc. – Overview
• 84: GNC Holdings Inc. – Business segments
• 85: GNC Holdings Inc. – Key offerings
• 86: GNC Holdings Inc. – Key customers
• 87: GNC Holdings Inc. – Segment focus
• 88: Herbalife Nutrition Ltd. – Overview
• 89: Herbalife Nutrition Ltd. – Business segments
• 90: Herbalife Nutrition Ltd. – Key offerings
• 91: Herbalife Nutrition Ltd. – Key customers
• 92: Herbalife Nutrition Ltd. – Segment focus
• 93: Lonza Group Ltd. – Overview
• 94: Lonza Group Ltd. – Business segments
• 95: Lonza Group Ltd. – Key offerings
• 96: Lonza Group Ltd. – Key customers
• 97: Lonza Group Ltd. – Segment focus
• 98: NOW Health Group Inc. – Overview
• 99: NOW Health Group Inc. – Product and service
• 100: NOW Health Group Inc. – Key offerings
• 101: NOW Health Group Inc. – Key customers
• 102: NOW Health Group Inc. – Segment focus
• 103: Currency conversion rates for US$
• 104: Research Methodology
• 105: Validation techniques employed for market sizing
• 106: Information sources
• 107: List of abbreviations
【掲載企業】
Amway Corp., Archer Daniels Midland Co., Arkopharma Laboratories, BASF SE, Bayer AG, Glanbia Plc, GNC Holdings Inc., Herbalife Nutrition Ltd., Lonza Group Ltd., NOW Health Group Inc.
【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。